PLUS THERAPEUTICS, INC. — Director's Dealing 2012

Dec 21, 2012

SEC Form 4/A — Form 4/A

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-12-19

Reporting Person: HEDRICK MARC H (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-19	Common Stock	P	10000	$2.85	Acquired	458238	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9600	Indirect
Common Stock	7500	Indirect
Restricted Stock (Common Stock)	36850	Direct
Restricted Stock (Common Stock)	25000	Direct

Footnotes

F1: Dr. Hedrick purchased the shares in connection with a public offering of company shares which closed on December 19, 2012.

F2: This amends the Form 4 filed earlier on 12/21/2012 to reflect that the shares will be held directly by Dr. Hedrick.

F3: These securities are owned by M Hedrick & T Hedrick TTEE Dr. Marc Hamilton Hedrick & TRA U/A DTD 09/13/1999.